Aeterna Zentaris
AEZS
#10128
Rank
โ‚ฌ15.08 M
Marketcap
4,93ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -1,90ย โ‚ฌ

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -1,76ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,03ย โ‚ฌ a decrease over its 2021 EPS that were of -1,57ย โ‚ฌ.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-1,90ย โ‚ฌ
2022-4,03ย โ‚ฌ157.14%
2021-1,57ย โ‚ฌ-41.48%
2020-2,68ย โ‚ฌ-64.46%
2019-7,54ย โ‚ฌ-240%
20185,38ย โ‚ฌ-122.32%
2017-24,12ย โ‚ฌ-53.53%
2016-51,89ย โ‚ฌ-86.71%
2015-390,60ย โ‚ฌ-35.21%
2014-602,91ย โ‚ฌ-216.67%
2013516,78ย โ‚ฌ-123.3%
2012-2.218ย โ‚ฌ-40.8%
2011-3.747ย โ‚ฌ-6.45%
2010-4.005ย โ‚ฌ-27.91%
2009-5.555ย โ‚ฌ-61.61%
2008-14.470ย โ‚ฌ83.61%
2007-7.881ย โ‚ฌ-195.31%
20068.268ย โ‚ฌ178.26%
20052.971ย โ‚ฌ-330%
2004-1.292ย โ‚ฌ-80.05%
2003-6.476ย โ‚ฌ17.78%
2002-5.498ย โ‚ฌ515.93%
2001-892,69ย โ‚ฌ-68.6%
2000-2.843ย โ‚ฌ124.47%
1999-1.267ย โ‚ฌ-3.63%
1998-1.314ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
6,34ย โ‚ฌ-459.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
1,78ย โ‚ฌ-200.79%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
2,56ย โ‚ฌ-244.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-0,31ย โ‚ฌ-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
4,21ย โ‚ฌ-338.66%๐Ÿ‡บ๐Ÿ‡ธ USA